ページ3 - 最高の腎生検医師 - トップ140名の医師

カール・J・オルドハーファー教授（医学博士）は、アスクレピオス・バルンベック病院腹部医療センターの一般・腹部外科および外科的腫瘍科のシニアコンサルタントであり、肝臓外科の専門家です。その医学的専門分野には、コンピュータナビゲーションを用いた肝臓放射線外科、転移外科、超音波メスを使用した手術、低侵襲腹部外科、肝胆道外科、および膵臓外科が含まれます。

会員資格

• 欧州泌尿器科学会（EAU）
• ハンガリー泌尿器科学会
• ハンガリー医師会

学位

博士（哲学）

国際経験

• 2011.11：腹腔鏡下泌尿器科手術上級コース - ライプツィヒ大学病院泌尿器科学教室、ライプツィヒ、ドイツ
• 2011.12：欧州泌尿器科学会 2週間臨床見学フェローシップ - オーフス大学病院スカイビー泌尿器科、オーフス、デンマーク
• 2013.02. - 2013.05.：欧州泌尿器科学会 3ヶ月研究フェローシップ；
• 2013.09. - 2014.09.：欧州泌尿器科学会 1年間研究フェローシップ
  • ルンド大学、実験医学研究所、微生物学・免疫学・グリコビオロジー学教室、ルンド、スウェーデン；
  • 微生物学・免疫学・グリコビオロジー学教室、実験医学研究所、ルンド大学、ルンド、スウェーデン

フォックス・ヴィオラ博士は、BKZゾーリンゲン血液腫瘍科・緩和医療科の主任医師です。同クリニックは、認定された集学的腫瘍センターです。フォックス博士は、ドイツおよびヨーロッパにおける腫瘍性疾患の薬物療法の第一人者であり、15年以上の臨床経験を有しています。

同博士は、ドイツ腫瘍学・血液腫瘍学会（GDHO）、ドイツ医師会、およびアメリカがん研究学会に所属しています。また、分子生物学の研究にも従事しており、その研究成果はがん治療および分子診断の発展に貢献しています。

主な専門領域は、化学療法、免疫療法、分子標的療法、および放射線療法です。フォックス博士は、革新的な治療法と患者への細やかな配慮で知られています。その取り組みにより、高い治癒率を達成し、同僚からの高い評価を得ています。

耳鼻咽喉科医。Asklepios Klinik St. Georg におけるLOR臓器腫瘍センター長

Dr. Axel Stang is a professor, Head Physician of Asklepios Barmbek Clinic, with a specialization in internal medicine, oncology, and hematology. He conducts antibody and molecular therapies to reduce tumor size, and is a member of multiple organizations and societies. Dr. Stang has published articles on the effectiveness of radiofrequency ablation in treating of metastatic colon cancer, and was a member of a research group that studied the effects of liver embolization. Patients can submit a request on the Bookimed website to get a consultation with the professor.

Associate Professor Dr. Yusuf AÇIKGÖZ
Specialization: Medical Oncology

Education:

• 2004-2011: İnönü University Faculty of Medicine
• 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
• 2017-2022: Health Sciences University, Medical Oncology

Professional Experience:

• 2016-2017: Bingöl City Hospital, Internal Medicine
• 2021-2022: Health Sciences University, Medical Oncology
• 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
• 2023-2024: Ohio State University, Medical Oncology
• 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital

Clinical Trials, Courses, Certifications:

Clinical Trials:

• 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
• 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)

Courses:

• 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
• 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
• 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
• 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
• 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association

Certifications:

• Ongoing: ECFMG Certification
• 2024: CITI Responsible Conduct of Research (The Ohio State University)
• 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
• 2024: CITI Human Subjects Protection (The Ohio State University)
• 2024: CITI Good Clinical Practice (The Ohio State University)
• 2023: Occupational English Test (OET)
• 2019: International English Language Testing System (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
• 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
• 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016

Memberships:

• American Society of Clinical Oncology (ASCO) - 2022
• Turkish Society of Medical Oncology - 2020

EDUCATION:

2000 - SSK Okmeydanı Training and Research Hospital, .

1996 - Istanbul University, Istanbul Faculty of Medicine

EXPERIENCE:

2019 - Istanbul Medipol University Pendik Hospital

2017 - 2019 - Private Adatıp Kurtköy Hospital

2005 - 2017 - Private Avicenna Umut Hospital

2003 - 2005 - SSK Yalova Regional Hospital

2002 - 2003 - Kayseri Military Hospital

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Oncologist, specialist in gastrointestinal cancer treatment

Dr. Ercan Ozden is a specialist in internal medicine and medical oncology. He earned his medical degree and completed his residency at Istanbul University, Cerrahpaşa Faculty of Medicine. He later received a subspecialty in medical oncology at Kocaeli University Faculty of Medicine from 2016 to 2020.

Dr. Ozden has worked in medical oncology at Şırnak State Hospital. He has also served as an internal medicine specialist at Bağcılar Private Safa Hospital and Küçükçekmece Batı Bahat Hospital. He has extensive clinical experience in both internal medicine and oncology.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Under his leadership, the hospital is actively expanding its services, including paediatric cardiology and intensive care, and is planning to establish an interdisciplinary center for parents and children on the basis of the Department of Paediatrics.

Dr. Propson's many years of experience have established him as a leading expert in neonatology and paediatric cardiology in Germany and Europe. His dedication and commitment to the highest level of care for young patients is reflected in his work. Dr. Propson's research and scientific publications demonstrate his in-depth knowledge and commitment to development in paediatrics.

For many years Dr. Propson worked as a leading physician in the Department of Paediatrics and Adolescent Medicine at the Leverkusen Clinic in Leverkusen, Germany, where he was also responsible for managing the paediatric intensive care unit. In addition to his primary work, Dr. Propson devotes a great deal of time to continuing education to ensure that his patients receive the most up-to-date treatments in his department.

His unique professional qualities and qualifications set him apart from other physicians. Dr. Propson's patients can rest assured that they are in good hands at the Department of Paediatrics and Adolescent Medicine at the Academic Hospital Solingen.

Membership in societies:

German Association of Physicians

Expert of scientific journals

Specialisations:

Emergency medicine

Intensive care

Paediatric cardiology

Neonatology

Work Experience:

2006: Graduation from the Faculty of Medicine

2006 - 2011: Specialization as a specialist in paediatrics and adolescent medicine.

2011 - 2023: Lead physician in the Department of Paediatrics and Adolescent Medicine at the Leverkusen Clinic.

2023: Chief physician in the Department of Paediatrics at the Academic Hospital Solingen.

With a Degree in Medicine and Surgery obtained at the Universidad Complutense in Madrid, he completed his studies in Nephrology as a Resident Doctor at the Clínico Universitario

San Carlos Hospital in Madrid where he completed his studies with Doctorate courses in Endocrinology.

Throughout his trajectory, Dr Marañés has carried out extensive work relating to his subject of interest, i.e., renal diseases associated to diabetic patients, and has taken part in the pancreatic islets transplant programme of patients with renal transplants. He is the author of numerous national and international medical-scientific publications.

Professional Experience:

• 2006 – Currently: Head of the Nephrology and Haemodialysis Unit of the Quirónsalud Marbella Hospital.

• 1996 – 2006: Medical Consultant of the Nephrology and Haemodialysis Unit of the Costa del Sol de Marbella Hospital from December 1996 to June 2006.

• 2004 – 2006: President of the Commission of Pharmacists and Therapists from 2004 to 2006.

• 1996: Nephrology Unit of the Getafe University Hospital.

• 1995-1996: Medical Consultant of the Nephrology Unit of the Virgen de la Luz Hospital in Cuenca.

• 1995 – 1996: Head of the Madrid-Oeste Dialysis Centre ascribed to the San Carlos University Hospital.

Research

• FIS Research Project (record: 93/0029-02) on the «Study of the effects of human pancreatic islets in Type I Diabetes patients".

• MAR Project, Morbidity and Mortality Anaemia Renal studies. Descriptive, prospective, multicentred and open study on case series. 2003-2004

• Nefrona Project: Observational, prospective and multicentred study on cardiovascular morbidity and mortality in patients at different stages of chronic renal disease.

• Department of Pathology. University of Edinburgh. United Kingdom, 1987.

The Nephrology and Hypertension Unit deals with non-surgical kidney diseases and with blood pressure. The professionals of the Nephrology Unit of Quirónsalud Marbella Hospital have vast experience in this speciality which, together with the latest drug technologies and equipment, helps them prevent and correct potential system unbalance and provide better recovery to patients. Due to the close connection between kidney conditions and the function of other vital organs, the specialists of the Nephrology team apply a multidisciplinary approach and work with the Cardiology, Endocrinology, Digestive System and Urology Units, amongst others.

Quirónsalud Marbella Hospital is the only private establishment in the area to be equipped with a Dialysis Unit provided with 20 stations in a facility situated in an adjacent building as an independent healthcare circuit. Due to our background in providing services to international patients, this Haemodialysis Unit has a team of interpreters for overseas patients providing various languages that guarantee a personalised service regardless of the country of origin.

Prof. Dr. Himmet Bora Uslu is a skilled nephrologist with more than 20 years of experience in kidney care. He focuses on kidney transplantation, chronic kidney disease, hemodialysis, peritoneal dialysis, hypertension, and inherited kidney disorders.

Dr. Uslu has published many articles in both international and national journals. He is dedicated to improving nephrology and is known for providing high-quality, evidence-based care for complex kidney conditions.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Zuhal Cakmak Peksen is a Family Medicine Specialist since 2017. She earned her MD from Çukurova University in 2010. She completed specialty training at Yüzüncü Yıl University between 2013 and 2017. She is currently studying for a bachelor’s degree in Health Management at Anadolu University (2024–present).

She has 15 years of clinical practice (2010–2025) across 8 institutions. Her experience includes research in Family Medicine (2013–2017) and work at several Family Health Centers. Since 2020, she has served at TOKİ Avrupa Family Health Center in Gaziosmanpaşa, Istanbul.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Özcan Uzun is a nephrology specialist. He earned his medical degree from Atatürk University Faculty of Medicine (2005-2011). He completed his internal medicine and nephrology training at Dokuz Eylül University Faculty of Medicine (2012-2016, 2018-2022).

Dr. Uzun treats acute and chronic kidney failure, diabetic kidney disease, Fabry disease, glomerulonephritis, hyponatremia, kidney disease related to heart failure, and vasculitis. He is skilled in managing diabetic kidney disease, treating glomerulonephritis, providing hemodialysis, and controlling hypertension.

He has worked as an internal medicine specialist at Batman Training and Research Hospital. He also served as a nephrology specialist at Yalova State Hospital. Dr. Uzun is a member of the Turkish Nephrology Association and the Izmir Medical Chamber.